NB's in dilemma over clinical investigation applications applications
This article was originally published in Clinica
Executive Summary
A lack of availability of patients for clinical trials is going to place new burdens of responsibility on EU notified bodies when it comes to their assessment of a manufacturers' documentation over whether to carry out a trial, as opposed to a literature search, in a clinical investigation.